Our seasoned columnists and guest writers offer insightful perspectives, thought-provoking opinions, and in-depth analysis on the most pressing issues of the day. From politics and policy to culture and society, our editorials aim to spark meaningful conversations and provide a platform for diverse voices and viewpoints.
Eli Lilly’s rapid growth in the GLP-1 drug market is expected to continue, while rival Novo Nordisk prepares for potential headwinds and a projected slowdown heading into 2026.
Stay informed with the latest health news, insights, and analysis. Get comprehensive coverage of breaking stories, key trends, and major developments shaping the health landscape. Our reporting brings context, clarity, and updates to help readers understand the issues that matter most. From policy decisions to real-world impacts, our journalism aims to inform and engage a broad audience worldwide across diverse global perspectives. Coverage is guided by accuracy, independence, and a commitment to responsible reporting with depth and balance. We also highlight expert opinions, data-driven insights, and on-the-ground reporting to provide a deeper understanding of evolving developments. Our goal is to help readers navigate complex topics with reliable information and thoughtful context. Stay updated with timely stories that keep you informed, aware, and engaged every day.
